Recent Headlines
Transnetyx Nears 12 Million Samples Genotyped, Gives 700 Working Years Back to Research
Transnetyx, an automated genotyping company, today announced that it will reach 12 million samples processed by the end of 2016. Since it began its operations in 2004, Transnetyx has served the research of more than 600 organizations – universities, hospitals and bioscience companies –... - November 16, 2016 - Transnetyx
New Gastrointestinal Pathogen Assays Available from ALPCO
ALPCO is now offering a line of research assays for the investigation of common bacterial and parasitic gastrointestinal (GI) pathogens including Giardia lamblia, Cryptosporidium spp., Blastocystis hominis, Entamoeba histolytica/dispar, and Clostridium difficile. These assays can be used to... - November 15, 2016 - ALPCO
New Ultrasensitive Active GLP-1 ELISA to Confidently Measure Fasted Levels of Active GLP-1
ALPCO has released its new STELLUX® Chemiluminescent Ultrasensitive Active GLP-1 ELISA, the most sensitive active GLP-1 assay on the market. - November 09, 2016 - ALPCO
Viral Vectors and Plasmid DNA Manufacturing to Witness 16% Annual Growth, Predicts Roots Analysis
Roots Analysis has announced the addition of the “Viral Vectors and Plasmid DNA Manufacturing Market, 2016-2026” report to its portfolio. The report features an extensive study of the rapidly growing market of gene therapy vectors. Kashish Goel, the principal analyst, said, “Gene... - November 02, 2016 - Roots Analysis
New Research Benchmarks Clinical Investigator Satisfaction with Pharma Sponsors and Central Laboratories
5-year Study Tracks Central Lab Performance and Identifies Opportunities for Pharma Sponsors to Improve Clinical Investigator Satisfaction. - October 24, 2016 - Life Science Strategy Group, LLC
Presentation from electroCore Shows That Healthcare Costs for Patients with a Primary Headache Diagnosis Cost Four Times More Than a Healthy Patient Due to Comorbidities
Research presented at the Academy of Managed Care Pharmacy (AMCP) Nexus in early October in Washington, DC, showed that 60 percent of adult patients who were diagnosed with primary headache had one or more comorbidities which raised the average annual cost of their healthcare to over $20,000. This... - October 22, 2016 - electroCore
Experimentica Ltd. Appoints New Director of In Vivo Pharmacology
Experimentica Ltd., a global ophthalmic contract research organization (CRO) today announced the appointment of Tamuna Bolkvadze, Ph.D. to Director In Vivo Pharmacology, effective immediately. Dr. Bolkvadze joined Experimentica Ltd. earlier in 2016 as Research Scientist and has been instrumental... - October 22, 2016 - Experimentica Ltd
Nerviano Medical Sciences Presents Data Regarding a Potent New Cytotoxic Molecule for ADC Generation
NMS-P945 is a potent, innovative and proprietary cytotoxic molecule in the nms pipeline, hbighly suited to conjugation with targeted antibodies. - October 20, 2016 - NMS Group
Bioscience Americas Senior Scientific Advisor Presents at Major FDA Public Hearing
Dr. Leslie Miller backs the creation of a Registry of Cell Therapy to provide guidelines for stem cell use in therapies and treatments. - October 17, 2016 - Bioscience Americas
Oxford AHSN Recognizes the SGC with Its Annual Public-Private Collaboration Award
Pioneering work to accelerate drug discovery earned the SGC the 2016 Oxford Academic Health Science Network (Oxford AHSN) collaboration award. - October 11, 2016 - The SGC
Bioscience Americas Sponsors "Solutions for a Healthier World Foundation"
Independent not-for-profit will provide stem cell therapies for the less fortunate. - October 06, 2016 - Bioscience Americas
Smart Wearables: The Future of Personalized Healthcare
Roots Analysis has announced the addition of the “Smart Wearables in Healthcare, 2016-2030” report to its list of offerings. The report provides a comprehensive analysis of the current market landscape with respect to key players and specific applications of the diverse range of... - October 03, 2016 - Roots Analysis
Children with High Grade Brain Tumors Will Soon be Able to Receive Cutting Edge Oncolytic Virus Therapy
Re-engineered Polio Virus with Dramatic Response in Adults to be Made Available to Children in a Phase 1 Clinical Trial Jointly Funded by The Andrew McDonough B+ Foundation and Solving Kids’ Cancer. - September 30, 2016 - Solving Kids' Cancer
PenThu®, a New Concept in the Clinical Research Industry
PenThu®, the first Interactive Guidance Management System (IGMS) in the clinical research industry developed by Europital, opened its doors widely to global clinical trials with the established new concept in guidance management within global projects. PenThu® is an innovative product from... - September 30, 2016 - Europital BVBA
MR Solutions to Supply Cryogen-Free 7T Simultaneous PET-MR Preclinical Imaging System for the Study of Alzheimer’s and Stroke at the University of Southern California
MR Solutions has received an order for a high-powered 7T, cryogen-free, preclinical PET-MRI multi-modality imaging system from the newly formed pre-clinical imaging resource at the Zilkha Neurogenetic Institute (ZNI) at the Keck School of Medicine of the University of Southern California... - September 22, 2016 - MR Solutions
Versatile, Transversal, Without Borders: MLS® Laser Therapy by ASAlaser in Veterinary Practice
Increasingly present in international Vet specialists’ clinics, the ASAlaser therapy collects new successes. 4 new cases confirm its full effectiveness. - September 22, 2016 - ASA srl
Editage Launches New Abstract and Cover Letter Development Service in Korea
Korean researchers can get effective abstracts and impressive cover letters written by subject-matter experts. High-quality abstracts and cover letters written by professionals can improve the chances of successful publication for academics. - September 21, 2016 - Cactus Communications
ALPCO Releases Versatile and Economical Chemiluminescent Plate Reader
ALPCO has launched its new STELLUX® Chemiluminescent Plate Reader, an economical and versatile system for any size lab. - September 20, 2016 - ALPCO
Bioscience Americas Announces New Cellular Immunotherapy Treatment
The treatment represents a breakthrough therapy that incorporates advanced stem cell protocols. - September 20, 2016 - Bioscience Americas
HDAC Inhibitors: Controlling Disease Propagation by Regulating Gene Expression
Roots Analysis has announced the addition of the “HDAC Inhibitors Market, 2016-2026” report to their list of offerings. It provides a comprehensive study on the current landscape of the evolving pipeline in this area. With five commercialized products, the market has gained the... - September 19, 2016 - Roots Analysis
Arbro Launches Nanotechnology Based Bioavailable Curcumin
Arbro Pharmaceuticals has launched SNEC30, a patented highly bioavailable Self Nano Emulsifying Curcumin formulation in 30 mg dose. Curcumin is the active ingredient of turmeric/Haldi which has been widely used in traditional medicine and home remedies in India for hundreds of years. Clinical... - September 18, 2016 - Arbro Pharmaceuticals
The Journal Headache Reports That electroCore’s Non-Invasive Vagus Nerve Stimulator is an Effective Bioelectric Medicine for Episodic Cluster Headache
In a multi-centered, sham-controlled study conducted in the United States, episodic cluster headache patients using the gammaCore non-invasive vagus nerve stimulation device (nVNS) had a significant and clinically meaningful benefit within 15 minutes of the treatment of the attack, as compared with... - September 14, 2016 - electroCore
The SGC Releases Enabling Information to Accelerate Drug Discovery
Data packages provide a crucial link between human genetics and disease biology to accelerate drug discovery in cancer and malaria. - September 13, 2016 - The SGC
Novel Drugs and Devices to Lower Intraocular Pressure: Revolutionary Advances Poised to Grow at a Rapid Rate
Roots Analysis has announced the addition of the “Novel Drugs and Devices to Lower Intraocular Pressure, 2016 - 2026” report to its list of offerings. The report provides a detailed study on the current market landscape, future trends and applications of these novel treatment options. - September 12, 2016 - Roots Analysis
MR Solutions Accelerates Sales of Its Preclinical Multi-Modality, High Field, Cryogen Free Scanners
Simultaneous and sequential PET-MR imaging systems with proven reference sites on show at 2016 WMIC in New York. - September 08, 2016 - MR Solutions
Editage and MA Healthcare Partner to Offer Editorial Services to Healthcare Professionals
Editage, a leader in English-language editing and publication support, has partnered with MA Healthcare, a global provider of nursing and medical education, to offer editorial services to healthcare professionals through MAHealthcare Author services. The services on offer through MAHealthcare Author services include editing, translation with editing, rapid technical review, artwork preparation, plagiarism check, and proofreading. - September 02, 2016 - Cactus Communications
Matrix IT Releases First Ever White Paper on Sterile Field Scanning
With the looming UDI deadline of September 24th, 2016, manufacturers are scrambling to reach solutions for their medical implants. In response, Matrix IT, Medical Tracking Systems, Inc. has released a white paper on sterile field scanning. - September 01, 2016 - Matrix Medical Tracking Systems
Clinical Trial Supplies
Clinical Trial Supplies 2nd Annual Symposium will be held in Brussels on the 20th and 21st of October 2016. CTS is a meeting dedicated in exploring the medical supplies required for Clinical Trials and Operations. Presented by prestigious pharmaceutical and biotechnology companies globally engaged... - August 25, 2016 - Business Dialogue
PBTF Unites with We Can to Form California Chapter
The We Can Pediatric Brain Tumor Network is now the California Chapter of the Pediatric Brain Tumor Foundation. - August 25, 2016 - Pediatric Brain Tumor Foundation
Non-Insulin Therapies for Diabetes: Growth Drivers and Future Outlook
Roots Analysis has announced the addition of “Non-Insulin Therapies for Diabetes: GLP-1 Agonists, DPP4 Inhibitors and SGLT2 Inhibitors, 2016 - 2026” report to its portfolio. The report provides a comprehensive analysis of the current market landscape of GLP-1 agonists, DPP4 inhibitors... - August 22, 2016 - Roots Analysis
MiTeGen Awarded 2016 Inc. 5000 Recognition
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, has been awarded a listing on the 2016 Inc. 5000. The Inc.5000 recognizes the country's top 5000 fastest-growing private companies. - August 18, 2016 - MiTeGen, LLC
ALPCO’s New and Improved Adiponectin ELISAs Allow Researchers to Confidently Study Type 2 Diabetes
ALPCO has released new and improved versions of their Total Adiponectin and HMW & Total Adiponectin ELISAs which allow researchers to confidently measure adiponectin for the study of high molecular weight (HMW) to total ratios. - August 17, 2016 - ALPCO
CellectCell, Inc. Announces Georgia Research Alliance Phase IIB Funding for the Commercialization of Novel Label-Free Cell Isolation Technology
CellectCell, Inc., a company that develops novel cell isolation and purification technology, announced today the completion of milestones related to its Phase IIA grant and receipt of Phase IIB grant funding from the Georgia Research Alliance (GRA). CellectCell’s initial focus is the... - August 12, 2016 - CellectCell, Inc.
Medical Technology and Practice Patterns Institute Announces That It Has Been Awarded an R01 Research Grant by the Agency for Healthcare Research and Quality
The Medical Technology and Practice Patterns Institute, Inc. (MTPPI) announces that it has been awarded an R01 research grant by the Agency for Healthcare Research and Quality (AHRQ). The grant will be used to investigate the impact of the End-Stage Renal Disease Prospective Payment System (ESRD PPS) reform that was enacted by Congress in 2011. - August 11, 2016 - Medical Technology and Practice Patterns Institute
MR Solutions Receives Queen’s Award from Lord Lieutenant of Surrey
MR Solutions has received the prestigious Queen’s Award for Enterprise from the Lord Lieutenant of Surrey at their Guildford headquarters in July to mark their achievement for innovation. MR Solutions received the accolade for the development and commercial success of its preclinical... - August 11, 2016 - MR Solutions
Marshfield Based Preventiongenetics Earns Accreditation for Global Testing
PreventionGenetics, located in Marshfield, WI has achieved ISO 15189:2012 certification through A2LA. PreventionGenetics is a genetic testing laboratory. - August 06, 2016 - PreventionGenetics
Accumen Partners with Mercy Health to Deliver Lab Excellence: Lowering Laboratory Costs and Blood Utilization and Improving Quality and Service
Mercy Health and Accumen Inc. to begin strategic clinical laboratory management partnership. - August 04, 2016 - Accumen Inc.
Baebies to Exhibit and Display FINDER Prototype at 2016 AACC Annual Scientific Meeting
Baebies, Inc., a company focused on advancing newborn screening and pediatric testing, today announced that the company will exhibit and display a prototype of FINDERTM at the 68th AACC Annual Scientific Meeting and Clinical Lab Expo. FINDER, currently under development, is a small, innovative and... - July 28, 2016 - Baebies, Inc.
Top Indiana Health System Partners with Accumen, Inc. for Comprehensive Patient Blood Management Program
Parkview Health to leverage Accumen’s patient-centered blood management partnership to drive down costs and improve care. - July 26, 2016 - Accumen Inc.
Braincure Biotech Study Indicates New Target for Combating Alzheimer’s
A team of researchers led by Sírnir Thorsson has established that the protein GPR3 could be instrumental in relieving cognitive deficits and mitigating the production of "amyloid plaques." - July 21, 2016 - BrainCure Biotech
Braincure Biotech Publishes Two New Reports
With more than 90 medicines in clinical trials or awaiting approval and knowledge of Alzheimer’s increasing, patients and caretakers look towards the future with high spirits. - July 21, 2016 - BrainCure Biotech
MR Solutions Receives Queen’s Award for Enterprise at Buckingham Palace
MR Solutions, the Surrey-based preclinical imaging company, received royal approval when attending a reception at Buckingham Palace to receive the prestigious Queen’s Award for Enterprise (Innovation). This was achieved in recognition of their development of the world’s first commercial... - July 21, 2016 - MR Solutions
MiTeGen Announces NANUQ™, an Automated High-Speed Cryocooling Device
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced the launch of their NANUQ™ automated, high-speed, cryocooling device for improved cryopreservation of small samples. - July 20, 2016 - MiTeGen, LLC
Bioscience Americas Outlines Growth Strategy
Opportunities abound for the world's leading developer of autologous stem cell treatment centers. - July 19, 2016 - Bioscience Americas
MiTeGen Announces Sentinel™, Real-Time Intensity Monitoring Beamstop System
MiTeGen LLC, a provider of innovative consumables for protein crystallization and X-ray diffraction to academic, pharmaceutical, industrial and government researchers around the world, announced the launch of their Sentinel™ Real-time Intensity Monitoring Beamstop Systems for X-ray beamlines. - July 15, 2016 - MiTeGen, LLC
Ezra Laboratories LLC Releases Nopiate Topical Pain Reliever
Nopiate is a topical pain reliever that does not require a prescription. Nopiate is FDA approved and is now available for the general public. - July 14, 2016 - Ezra Laboratories LLC
Trial Runners LLC is a “Great Place To Work®”
Trial Runners was certified as a great workplace today by the independent analysts at Great Place to Work®. Trial Runners earned this credential based on extensive ratings provided by its employees in anonymous surveys. - July 13, 2016 - Trial Runners
Vaccine Contract Manufacturing: a Niche Segment Poised to Become a Global Market by 2026
Roots Analysis has announced the addition of the “Vaccine Contract Manufacturing Market, 2016-2026” report to its list of offerings. The report provides an extensive study of the current market landscape, future trends and opportunities related to vaccine contract manufacturing. It... - July 12, 2016 - Roots Analysis
North Carolina State Epidemiologist Takes Office as President of National Public Health Council
Chief of the Epidemiology Section of the North Carolina Division of Public Health Dr. Megan Davies took office in June as the president of the Council of State and Territorial Epidemiologists (CSTE). Dr. Davies has worked as an epidemiologist for over 18 years, first with the Centers for Disease... - July 08, 2016 - Council of State and Territorial Epidemiologists
Zifo RnD Solutions is Recognised as India’s Best Companies to Work For
Zifo RnD Solutions announced today that it has been recognised as one of India’s Best Companies to Work For 2016 by the Great Place to Work® Institute. Every year, more than 7000 companies from over 45 countries join the Great Place to Work® assessment and recognition programme in... - July 07, 2016 - Zifo